AstraZeneca discloses physician relationships; IRS wants $1.9B from Glaxo;

> AstraZeneca has become the latest pharmaceutical company to begin disclosing data on its relationships with doctors, following Merck, Eli Lilly, GlaxoSmithKline and others. FiercePharma

> The IRS is demanding as much as $1.9 billion from GlaxoSmithKline, asserting that the company used accounting chicanery to dodge taxes. FiercePharma

> While they remained basically static last month, hospital prices have climbed 2.4 percent since April 2008, according to new federal data. FierceHealthFinance

>  FierceContentManagement's Ron Miller talks about his experience at MIT CIO conference and, in particular, a session on Connected Healthcare Systems. FierceContentManagement

And Finally... It's not every day that a 6-year-old can save a life. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.